Director Seizinger Bernd R. bought ONCOLYTICS BIOTECH INC ($ONCY) shares on the open market three times in the last year, totaling 187 thousand dollars. His most recent purchase occurred on February 12, 2026. These buys rank him 1,644th among nearly 5,000 insiders by purchase amount, below the average of 1.46 million dollars per insider and 3.3 transactions. He reported no open market sales.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 12, 2026 | ONCOLYTICS BIOTECH INC | $ONCY | Seizinger Bernd R. | Director | P | Common Shares | 40000 | $0.85 | 566,991.0000 | 80,020,131 | 7.59% | 0.05% |
| Feb. 11, 2026 | ONCOLYTICS BIOTECH INC | $ONCY | Seizinger Bernd R. | Director | P | Common Shares | 60000 | $0.83 | 526,991.0000 | 80,020,131 | 12.85% | 0.07% |
| Jan. 16, 2026 | ONCOLYTICS BIOTECH INC | $ONCY | Seizinger Bernd R. | Director | P | Common Shares | 100000 | $1.04 | 466,991.0000 | 80,020,131 | 27.25% | 0.12% |
| June 5, 2025 | Aprea Therapeutics, Inc. | $APRE | Seizinger Bernd R. | Director | A | Common Stock | 1045 | $0.00 | 45,775.0000 | 5,993,866 | 2.34% | 0.02% |
| June 5, 2025 | Aprea Therapeutics, Inc. | $APRE | Seizinger Bernd R. | Director | A | Stock Options (Right to Buy) | 4185 | $0.00 | 4,185.0000 | 5,993,866 | 9999.99% | 0.07% |
| Oct. 11, 2024 | Aprea Therapeutics, Inc. | $APRE | Seizinger Bernd R. | Director | P | Common Stock | 10000 | $2.68 | 44,730.0000 | 5,939,755 | 28.79% | 0.17% |
| June 20, 2024 | Aprea Therapeutics, Inc. | $APRE | Seizinger Bernd R. | Director | A | Stock Options (Right to Buy) | 4185 | $0.00 | 4,185.0000 | 4,198,326 | 9999.99% | 0.10% |
| June 20, 2024 | Aprea Therapeutics, Inc. | $APRE | Seizinger Bernd R. | Director | A | Common Stock | 1045 | $0.00 | 34,730.0000 | 4,198,326 | 3.10% | 0.02% |
| March 13, 2024 | Aprea Therapeutics, Inc. | $APRE | Seizinger Bernd R. | Director | P | Tranche A Warrant | 3430 | $0.00 | 3,430.0000 | 3,617,607 | 9999.99% | 0.09% |
| March 13, 2024 | Aprea Therapeutics, Inc. | $APRE | Seizinger Bernd R. | Director | P | Tranche B Warrant | 3430 | $0.00 | 3,430.0000 | 3,617,607 | 9999.99% | 0.09% |
| March 13, 2024 | Aprea Therapeutics, Inc. | $APRE | Seizinger Bernd R. | Director | P | Common Stock | 6860 | $7.29 | 33,685.0000 | 3,617,607 | 25.57% | 0.19% |
| Feb. 5, 2024 | Aptose Biosciences Inc. | $APTOF | Seizinger Bernd R. | Not found | A | Director Stock Option (Right to Buy) | 3333 | $0.00 | 3,333.0000 | 0 | 9999.99% | 0.00% |